Abstract
Introduction: Chimeric antigen receptor T cells (CAR-Ts) targeting CD19 represent a significant advance in treatment for patients with relapsed/refractory B-cell malignancies. Although a significant minority of recipients are women during their reproductive years, there is a paucity of data regarding pregnancy and neonatal outcomes in women previously treated with CAR-T. This is important as maternal T cells are known to cross the placenta and into breastmilk during pregnancy and breastfeeding, respectively. Case Presentation: Here we present two successful pregnancies following CAR-T therapy where both neonates were initially breastfed. These represent the first cases of neonates born following CAR-T therapy comprehensively described in medical literature. Conclusion: Pregnancy following CAR-T therapy does not appear to be associated with adverse neonatal outcomes. Further work is required to delineate the outcomes in this population.
Journal Section:
Novel Insights from Clinical Practice
References
1.
Denlinger
N
, Bond
D
, Jaglowski
S
. CAR T-cell therapy for B-cell lymphoma
. Curr Probl Cancer
. 2022
;46
(1
):100826
. 2.
Pasvolsky
O
, Kebriaei
P
, Shah
BD
, Jabbour
E
, Jain
N
. Chimeric antigen receptor T-cell therapy for adult B-cell acute lymphoblastic leukemia: state-of-the-(C)ART and the road ahead
. Blood Adv
. 2023
;7
(14
):3350
–60
. 3.
UK Cancer Research
. 2023
. Available from:
https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/non-hodgkin-lymphoma4.
Kinder
JM
, Stelzer
IA
, Arck
PC
, Way
SS
. Immunological implications of pregnancy-induced microchimerism
. Nat Rev Immunol
. 2017
;17
(8
):483
–94
. 5.
Molès
JP
, Tuaillon
E
, Kankasa
C
, Bedin
AS
, Nagot
N
, Marchant
A
, et al. Breastfeeding-related maternal microchimerism
. Nat Rev Immunol
. 2017
;17
(11
):729
–1
. 6.
Cosgrove
C
, Dellacecca
ER
, van den Berg
JH
, Haanen
JB
, Nishimura
MI
, Le Poole
IC
, et al. Transgenerational transfer of gene-modified T cells
. J Immunother Cancer
. 2019
;7
(1
):186
. 7.
Ligon
JA
, Fry
A
, Maher
JY
, Foley
T
, Silbert
S
, Yates
B
, et al. Fertility and CAR T-cells: current practice and future directions
. Transplant Cell Ther
. 2022
;28
(9
):605.e1
–8
. 8.
Gathings
WE
, Lawton
AR
, Cooper
MD
. Immunofluorescent studies of the development of pre-B cells, B lymphocytes and immunoglobulin isotype diversity in humans
. Eur J Immunol
. 1977
;7
(11
):804
–10
. 9.
Hofman
FM
, Danilovs
J
, Husmann
L
, Taylor
CR
. Ontogeny of B cell markers in the human fetal liver
. J Immunol
. 1984
;133
(3
):1197
–201
. 10.
Shearer
WT
, Rosenblatt
HM
, Gelman
RS
, Oyomopito
R
, Plaeger
S
, Stiehm
ER
, et al. Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study
. J Allergy Clin Immunol
. 2003
;112
(5
):973
–80
. 11.
Comans-Bitter
WM
, de Groot
R
, van den Beemd
R
, Neijens
HJ
, Hop
WC
, Groeneveld
K
, et al. Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations
. J Pediatr
. 1997
;130
(3
):388
–93
. 12.
Maude
SL
, Frey
N
, Shaw
PA
, Aplenc
R
, Barrett
DM
, Bunin
NJ
, et al. Chimeric antigen receptor T cells for sustained remissions in leukemia
. N Engl J Med
. 2014
;371
(16
):1507
–17
. 13.
Borriello
F
, Pasquarelli
N
, Law
L
, Rand
K
, Raposo
C
, Wei
W
, et al. Normal B-cell ranges in infants: a systematic review and meta-analysis
. J Allergy Clin Immunol
. 2022
;150
(5
):1216
–24
. © 2024 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2024
You do not currently have access to this content.
